Skip to main content

What the FDA labels say about taking them together

Rifampin and tasimelteon

Tasimelteon's FDA label of August 4, 2026 names rifampin in its drug interactions section; the rifampin label PlainMeds reads does not name tasimelteon. The tasimelteon label: “DRUG INTERACTIONS Strong CYP1A2 inhibitors (e.g., fluvoxamine): Avoid use of HETLIOZ in combination with strong CYP1A2 inhibitors because of increased exposure Strong CYP3A4 inducers (e.g., rifampin):”

Check it at the source: the rifampin FDA label on DailyMed (effective February 11, 2026, Lupin Pharmaceuticals, Inc.); the tasimelteon FDA label on DailyMed (effective August 4, 2026, Vanda Pharmaceuticals Inc.).

What does the rifampin label say about tasimelteon?

Rifampin's label (effective February 11, 2026) does not name tasimelteon in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (rifampin), Lupin Pharmaceuticals, Inc., effective February 11, 2026 (SPL set b56004f0-f23d-47f6-80c7-39884fccbccc), via openFDA; the full label on DailyMed

What does the tasimelteon label say about rifampin?

Tasimelteon label, drug interactions

DRUG INTERACTIONS Strong CYP1A2 inhibitors (e.g., fluvoxamine): Avoid use of HETLIOZ in combination with strong CYP1A2 inhibitors because of increased exposure ( 7.1 , 12.3 ) Strong CYP3A4 inducers (e.g., rifampin):

Source: FDA drug label (Hetlioz), Vanda Pharmaceuticals Inc., effective August 4, 2026 (SPL set ca4a9b63-708e-49e9-8f9b-010625443b90), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

13Rifampin generic labelers
3Tasimelteon generic labelers
RifampinTasimelteon
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)$0.679 per capsule 300 mg capsule$228.25 per capsule 20 mg capsule
Shortage nowIn shortageNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?